Healthtech Series A Investors & VC Firms
2309 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
Portugal Ventures
PortoPre-Seed–Series C$54K – $1.6M
12 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Growth$16.2M
16 people
Brightstone Venture Capital
MinneapolisSeed–Growth$250K – $10M
11 people
Fountain Healthcare Partners
DublinSeed–Series A$10.8M – $16.2M
8 people
Senovo
MunichSeed–Series A$1.1M – $5.4M
8 people
VestedWorld
ChicagoSeed–Series A$500K – $1M
8 people
Lewis & Clark Ventures
St. LouisSeed–Series A$2M – $3M
12 people
SCI Ventures
LondonSeed–Series B
18 people
Noetic
TorontoSeed–Series A
13 people
OMX Ventures
LincolnshireSeed–Series A
10 people
Bios Partners
Fort WorthSeed–Growth
17 people
Cherubic Ventures
Grand CaymanPre-Seed–Series A
8 people
Genoa Ventures
San FranciscoPre-Seed–Series A
11 people
JK&B Capital
ChicagoSeed–Late Stage
9 people
Pender Ventures
VancouverSeed–Growth
15 people
Suncoast Ventures
Walnut CreekPre-Seed–Series A
15 people
PsyMed Ventures
BerkeleyPre-Seed–Series A
13 people
Tabula Rasa Ventures
Pre-Seed–Series A$50K – $1M
14 people
Hinge Capital
HaddonfieldPre-Seed–Series A$500K – $1M
3 people
Celtic House Asia Partners
TorontoPre-Seed–Late Stage
4 people
ANRI
TokyoPre-Seed–Growth
11 people
BVCF
ShanghaiSeries A–Series B$5M
18 people
Comet Labs
San FranciscoSeed–Series A
9 people
KK Fund
SingaporePre-Seed–Series A
10 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Healthtech Investors & VC Firms (4190)Series A Investors & VC Firms in United States (3838)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Healthtech Investors & VC Firms in United States (2436)Series A Investors & VC Firms in Europe (2383)
Data sourced from public filings and firms' own websites — see our methodology.



























































































